Clincosm LogoSign in Get a demo

Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer

Sponsor
Xijing Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05740852
Collaborator
(none)
1,688
Enrollment
85
Actual Duration (Months)

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about in describe participant population.

The main questions it aims to answer are:

  • What are the risk factors of postoperative pulmonary infection in patients with esophageal cancer？

  • Whether we could establish a clinical prediction model to provide basis for early clinical intervention or not? Participants will describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items. If there is a comparison group: Researchers will compare insert groups to see if insert effects.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Data were collected from the electronic medical records of Xijing Hospital. Each record is entered by two team members working simultaneously to ensure data accuracy.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1688 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer
    Actual Study Start Date :
    Jan 1, 2016
    Actual Primary Completion Date :
    Oct 31, 2021
    Actual Study Completion Date :
    Jan 31, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Infection

    Patients who developed pulmonary infection after radical resection of tumor
    Without infection

    Patients without pulmonary infection after radical resection of tumor

    Outcome Measures

    Primary Outcome Measures

    1. Pneumonia [A week after radical resection of tumor]

      Pulmonary infection in patients with esophageal cancer after radical resection of tumor

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Diagnosis of esophageal cancer;

    • Radical resection of tumor for the first time;

    • No distant metastasis was observed in preoperative examination

    Exclusion Criteria:

    • Patients with preoperative pulmonary infection or symptoms of pulmonary infection;

    • Patients with tracheal intubation assisted ventilation before surgery;

    • Patients with preoperative lung imaging changes or abnormal white blood cells in blood routine;

    • Patients undergoing emergency surgery;

    • Patients with other cancers;

    • Patients with incomplete clinical data.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Xijing Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xijing Hospital
    ClinicalTrials.gov Identifier:
    NCT05740852
    Other Study ID Numbers:
    • XijingHCJF
    First Posted:
    Feb 23, 2023
    Last Update Posted:
    Feb 23, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Esophageal Neoplasms

    Study Results

    No Results Posted as of Feb 23, 2023